| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
|
Teisseyre, Maxime
|
|
|
6 |
4 |
p. 1183-1188
|
article
|
| 2 |
A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD
|
Metzger, Maureen
|
|
|
6 |
4 |
p. 894-904
|
article
|
| 3 |
A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
|
Hoxha, Elion
|
|
|
6 |
4 |
p. 928-935
|
article
|
| 4 |
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy
|
Roccatello, Dario
|
|
|
6 |
4 |
p. 1081-1087
|
article
|
| 5 |
Association of Local Unit Sampling and Microbiology Laboratory Culture Practices With the Ability to Identify Causative Pathogens in Peritoneal Dialysis-Associated Peritonitis in Thailand
|
Kanjanabuch, Talerngsak
|
|
|
6 |
4 |
p. 1118-1129
|
article
|
| 6 |
Author Reply to Comment on “Assessment of Plasma Oxalate Concentration in Patients With CKD” by Oka et al.
|
Pfau, Anja
|
|
|
6 |
4 |
p. 1194-1195
|
article
|
| 7 |
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events
|
Isik, Busra
|
|
|
6 |
4 |
p. 1022-1031
|
article
|
| 8 |
Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients
|
Massicotte-Azarniouch, David
|
|
|
6 |
4 |
p. 1041-1049
|
article
|
| 9 |
C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question
|
Werion, Alexis
|
|
|
6 |
4 |
p. 878-880
|
article
|
| 10 |
Congenital Anomalies of the Kidney and Urinary Tract and Adulthood risk of Urinary Tract Cancer
|
Calderon-Margalit, Ronit
|
|
|
6 |
4 |
p. 946-952
|
article
|
| 11 |
Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
|
Husain-Syed, Faeq
|
|
|
6 |
4 |
p. 872-874
|
article
|
| 12 |
Coronavirus Disease 2019 in Patients With End-Stage Kidney Disease on Hemodialysis in Guatemala
|
Sosa, Regina
|
|
|
6 |
4 |
p. 1110-1117
|
article
|
| 13 |
COVID-19–Associated Graft Loss From Renal Infarction in a Kidney Transplant Recipient
|
Webb, Christine
|
|
|
6 |
4 |
p. 1166-1169
|
article
|
| 14 |
COVID-19 Vaccination Acceptance and Hesitancy in Dialysis Staff: First Results From New York City
|
Pamplona, Gemma M.
|
|
|
6 |
4 |
p. 1192-1193
|
article
|
| 15 |
Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19
|
Hardenberg, Jan-Hendrik B.
|
|
|
6 |
4 |
p. 905-915
|
article
|
| 16 |
Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City
|
Charytan, David M.
|
|
|
6 |
4 |
p. 916-927
|
article
|
| 17 |
Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction
|
Kudose, Satoru
|
|
|
6 |
4 |
p. 936-945
|
article
|
| 18 |
Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes
|
Daloul, Reem
|
|
|
6 |
4 |
p. 986-994
|
article
|
| 19 |
Eosinophilia Due to Central Venous Catheter in Hemodialysis Patients
|
Chapelet-Debout, Agnès
|
|
|
6 |
4 |
p. 1189-1191
|
article
|
| 20 |
Erratum to “Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis – Subgroup Analyses of the CALIPSO Trial.” Kidney Int. Rep. 2020;5:2178–2182
|
|
|
|
6 |
4 |
p. 1196
|
article
|
| 21 |
Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes
|
Timmermans, Sjoerd A.M.E.G.
|
|
|
6 |
4 |
p. 1099-1109
|
article
|
| 22 |
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
|
Ariceta, Gema
|
|
|
6 |
4 |
p. 1088-1098
|
article
|
| 23 |
Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft Outcome
|
Sullivan, Harold C.
|
|
|
6 |
4 |
p. 875-877
|
article
|
| 24 |
Immune-Complex Glomerulonephritis After COVID-19 Infection
|
Sethi, Sanjeev
|
|
|
6 |
4 |
p. 1170-1173
|
article
|
| 25 |
Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients
|
Jourdain, Pierre
|
|
|
6 |
4 |
p. 1161-1165
|
article
|
| 26 |
Living Organ Donor Health Care Priorities During the COVID-19 Pandemic
|
Zaidi, Hasan
|
|
|
6 |
4 |
p. 1151-1155
|
article
|
| 27 |
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
|
Ashoor, Isa F.
|
|
|
6 |
4 |
p. 995-1002
|
article
|
| 28 |
Natural Killer Cell Large Granular Lymphocyte Leukemia-Induced Glomerulonephritis
|
Isnard, Pierre
|
|
|
6 |
4 |
p. 1174-1177
|
article
|
| 29 |
N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
|
Sasaki, Takaya
|
|
|
6 |
4 |
p. 976-985
|
article
|
| 30 |
Paraneoplastic REG1α Cast Nephropathy Associated With Mixed Acinar-Neuroendocrine Carcinoma
|
Nasr, Samih H.
|
|
|
6 |
4 |
p. 1178-1182
|
article
|
| 31 |
Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians
|
Wang, Yeli
|
|
|
6 |
4 |
p. 962-975
|
article
|
| 32 |
Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
|
Mallett, Andrew J.
|
|
|
6 |
4 |
p. 1032-1040
|
article
|
| 33 |
Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
|
Chung, Erin
|
|
|
6 |
4 |
p. 1003-1014
|
article
|
| 34 |
Plasma Oxalate Concentration and Patients With CKD
|
Oka, Yoshinari
|
|
|
6 |
4 |
p. 1194
|
article
|
| 35 |
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
|
El Ters, Mireille
|
|
|
6 |
4 |
p. 953-961
|
article
|
| 36 |
Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis
|
Nataatmadja, Melissa
|
|
|
6 |
4 |
p. 1058-1065
|
article
|
| 37 |
Renin-Angiotensin-Aldosterone System Inhibition and Mineralocorticoid Receptor Antagonists: The Overriding Importance of Enablers and Dampers
|
Epstein, Murray
|
|
|
6 |
4 |
p. 869-871
|
article
|
| 38 |
Risk for Significant Kidney Function Decline After Acute Kidney Injury in Adults With Hematologic Malignancy
|
May, Heather P.
|
|
|
6 |
4 |
p. 1050-1057
|
article
|
| 39 |
Rituximab in Membranous Nephropathy
|
Gauckler, Philipp
|
|
|
6 |
4 |
p. 881-893
|
article
|
| 40 |
Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
|
Gouin, Anna
|
|
|
6 |
4 |
p. 1015-1021
|
article
|
| 41 |
Survey of Current Practices of Outpatient Hemodialysis for AKI Patients
|
Ortiz-Soriano, Victor
|
|
|
6 |
4 |
p. 1156-1160
|
article
|
| 42 |
Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
|
Canney, Mark
|
|
|
6 |
4 |
p. 1130-1140
|
article
|
| 43 |
Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
|
Wetmore, James B.
|
|
|
6 |
4 |
p. 1141-1150
|
article
|
| 44 |
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort
|
Palmer, Matthew B.
|
|
|
6 |
4 |
p. 1066-1080
|
article
|
Journal description